Key Considerations When Choosing A CDMO

By Alex Weaver, Sr Director of Engineering, PCI Pharma Services

As outsourcing becomes the norm across the pharmaceutical manufacturing landscape, the complexities and considerations associated with the increasingly unique drug products on the market today have made selecting the right CDMO partner more difficult – and more critical – than ever.

When looking for the right CDMO, pharmaceutical companies can help ensure their project’s success by focusing on five primary attributes in their potential partner: quality, flexibility, speed, cost-effectiveness, and experience. By evaluating a CDMO’s track record, understanding its internal processes, and gauging its willingness to conform to the processes and procedures of its clients, pharmaceutical companies can make informed choices and achieve better outcomes as a result.

In this article, explore these five key attributes of a great CDMO partner and what PCI Pharma Services can offer as part of its comprehensive approach to contract manufacturing.